EUVIMEDEUVIMED entdecken
Crossref

Chrysin Cocrystals: Prediction, Preparation, Characterization, and In Vitro/In Vivo Evaluation

Baoxi Zhang iD, Yifei Xie iD, Weiwen Ji, Li Zhang iD, Qi Wang, Shiying Yang iD, Dezhi Yang iD, Yang Lu iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c00397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Baoxi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Innovative Drug Discovery and Polymorphic Research for Cerebrovascular Diseases, Institute of Materia Medica, Chinese Acade…. Hauptthemen laut MEDLINE: Flavonoids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Key Technology Research and Development Program of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, crystal engineering was employed to enhance the solubility and druggability of Chrysin (CHR). Four nitrogen heterocyclic compounds, including piperazine (PIP), 4,4'-bipyridine (BIP), imidazole (IMI), and sophoridine (SOP), were investigated using computational screening methodologies. Screening experiments were conducted to validate the computational screening results, and four CHR crystals were successfully prepared, three of which were reported for the first time. The structures of these cocrystals were characterized by using single-crystal X-ray diffraction (SXRD), powder X-ray diffraction (PXRD), and thermal analysis. The spatial structure, arrangement, interactions, and associations were analyzed. Additionally, physical stability, apparent solubility, and biological evaluation were performed to assess those cocrystals. Finally, the CHR-SOP cocrystal shows a significant improvement in solubility and dissolution rate, making it a promising candidate for further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsSolubilityCrystallizationX-Ray DiffractionAnimalsCrystallography, X-Ray

Stichwörter der Autor:innen

chrysincocrystalimproved druggabilityscreening

Substanzen

chrysinFlavonoids

Autor:innen und Institutionen

  • Beijing Key Laboratory of Innovative Drug Discovery and Polymorphic Research for Cerebrovascular Diseases, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 10005…
  • Aviation Medical Appraisal Center, Civil Aviation Flight University of China, Guanghan 618307, China.

ORCID-Profile: Baoxi Zhang, Yifei Xie, Li Zhang, Shiying Yang, Dezhi Yang, Yang Lu

Förderung

  • Chinese Academy of Medical Sciences
  • National Natural Science Foundation of China
  • Key Technology Research and Development Program of Shandong Province
  • Tianchi Talent Project
  • Independent Innovation and Achievement Transformation Plan Project of Zaozhuang City
  • Tengzhou Talent Project

Zitieren

APA

Zhang, B., Xie, Y., Ji, W., Zhang, L., Wang, Q., Yang, S., Yang, D., & Lu, Y. (2026). Chrysin Cocrystals: Prediction, Preparation, Characterization, and In Vitro/In Vivo Evaluation. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00397

Vancouver

Zhang B, Xie Y, Ji W, Zhang L, Wang Q, Yang S, et al. Chrysin Cocrystals: Prediction, Preparation, Characterization, and In Vitro/In Vivo Evaluation. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c00397

BibTeX
@article{Zhang2026,
  author = {Zhang, Baoxi and Xie, Yifei and Ji, Weiwen and Zhang, Li and Wang, Qi and Yang, Shiying and Yang, Dezhi and Lu, Yang},
  title = {Chrysin Cocrystals: Prediction, Preparation, Characterization, and In Vitro/In Vivo Evaluation},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c00397}
}
Kostenlos starten →